Greg Erman is president and CEO of EmpiraMed and the former president and CEO of Illumasonix, Precision Biopsy, Renalworks Medical Corporation, MarketSoft Corporation, and Waypoint Software Corporation. He incubated around 250 academic medical research projects over 10 years, raised $100M in venture capital, and successfully grew businesses to about $20M in annual revenue. Each of Erman’s three VC-backed companies exited to large public corporations and generated returns of up to 12X investment. He holds Bachelors’ in engineering and a MBA in marketing with high honors from Rutgers University, served as a lecturer at Harvard Medical School, and is on the board of directors for Access Quality Health, i-Nalysis, and more.
